Description

Retatrutide 10 mg Research Product

Retatrutide 10 mg is supplied as a lyophilized research compound in a clear 3 mL vial. It is identified by compound name and quantity for legitimate laboratory, analytical, and scientific research applications.

Retatrutide, also known by the research identifier LY3437943, is an investigational compound being studied as a GIP, GLP-1, and glucagon receptor agonist. It remains under clinical investigation and is not currently available as an FDA-approved product for public use.

The presence of retatrutide in laboratory or clinical research does not establish regulatory approval, suitability for personal use, or equivalence to an approved medication.

Retatrutide 10 mg Product Details

• Compound: Retatrutide
• Research identifier: LY3437943
• Quantity: 10 mg
• Form: Lyophilized research material
• Vial capacity: 3 mL
• SKU: IL-RETA-10
• Storage: Follow the storage information supplied with the applicable product or batch documentation
• Documentation: Batch-specific documentation may be provided when available

Product appearance, packaging, and documentation may vary slightly by batch. Review the applicable label and available documentation before beginning laboratory or analytical work.

Retatrutide Research and Product Standards

Retatrutide is currently being evaluated in Phase 3 clinical studies involving obesity, type 2 diabetes, cardiovascular outcomes, and related conditions. These ongoing studies do not make research-market products approved medications or establish that independently sold materials are suitable for personal use.

To better understand certificates of analysis, identity testing, purity results, and the limits of laboratory documentation, visit the Infinite Longevity Learning Center.

For questions about availability, orders, shipping, or available documentation, please contact Infinite Longevity.

For regulatory information, review the FDA’s guidance regarding unapproved GLP-1 products. The FDA has specifically warned about unapproved GLP-1 products and has taken enforcement action involving websites marketing retatrutide for sale.

Important Research-Use Notice

Retatrutide 10 mg is intended solely for legitimate laboratory, analytical, and scientific research. It is not intended for human or animal use.

Infinite Longevity does not provide medical advice, dosing information, reconstitution instructions, administration guidance, treatment recommendations, or individualized product protocols.

Purchasers are responsible for understanding the research-use designation, maintaining appropriate laboratory procedures, and complying with all applicable laws, regulations, and institutional requirements.